on-contact determination of heart failure
Not Applicable
- Conditions
- Health Condition 1: I509- Heart failure, unspecified
- Registration Number
- CTRI/2021/12/038718
- Lead Sponsor
- Turtle Shell Technologies Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Referred for cardiac echocardiography
2.Able to give informed consent directly or via guardian
3.Above the age of 18 years
Exclusion Criteria
1.Known pregnancy
2.Spinal Implant
3.Pacemaker ââ?¬â?? single & double channel
4.Other condition that makes them unable to lie flat (severe scoliosis, injury etc.) or unable to perform SpO2.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To identify parameters/variables from Ballistocardiography (BCG)signal to determine Myocardial Performance Index (MPI) and Ejection Fraction (EF) <br/ ><br>2.To calculate Myocardial Performance Index (MPI) and Left Ventricular Ejection Time (LVEF) <br/ ><br>3.To derive a signal processing framework and an adaptive predictive model algorithm for EF calculation vis-a-vis the BCG signal <br/ ><br>4.To correlate the gold standard LVEF from Biplane Simson�s Method from 2D ECHO against EF <br/ ><br>Timepoint: At Baseline
- Secondary Outcome Measures
Name Time Method 1.To identify the degree of correlation between EF and MPI calculated via the 2D TTE Echocardiography and Dozee�s novel algorithm for BCG derived EF and MPI. <br/ ><br>2.To validate Dozee�s BCG derived EF and MPI calculation against the 2D ECHO derived EF and MPI. <br/ ><br>3.Based on Dozee�s BCG derived EF, to be able to screen and classify participants as LV dysfunction (EF less than 45%) versus LV Normal (EF greater than 50%) <br/ ><br>Timepoint: At Baseline